ALPL and Sepsis: The results obtained from in vivo and in vitro pharmacological inhibition of TNAP enzymatic activity with SBI-425 demonstrate that the loss of TNAP’s activity during systemic proinflammatory states, i.e. sepsis, enhances disruption of the brain-immune axis.